Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Boryung Pharmaceutical Company Ltd -Company Report' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Boryung Pharmaceutical Company, Ltd.-Therapeutic Competitors Report | Mar 2011 | £220 | 100% |
| Hepatic Injury Global Clinical Trials Review Q1, 2011 |
Apr 2011 | £630 | 76% |
| Renal Pain Global Clinical Trials Review H2, 2011 |
Nov 2011 | £630 | 75% |
| Hypertension Global Clinical Trials Review, Q1 2011 |
Jan 2011 | £630 | 75% |
| Muscle Wasting Disorders - Pipeline Review H1 2012 |
Jan 2012 | £325 | 74% |
| Encephalitis Global Clinical Trials Review H2 2011 |
Nov 2011 | £630 | 73% |
| Japanese Encephalitis – Pipeline Review H2 2011 |
Dec 2011 | £315 | 71% |
| Hypertension - Pipeline Review Q1 2011 |
Feb 2011 | £315 | 68% |
| Erythropoietin (EPO) Competitor Analysis |
Jan 2011 | £415 | 66% |
| Anemia - Pipeline Review H2 2011 |
Sep 2011 | £315 | 63% |
| Generic Pharmaceuticals Industry Report - Global Business Performance Analysis |
Aug 2011 | £950 | 63% |
| Rheumatoid Arthritis - Pipeline Review H2 2011 |
Sep 2011 | £315 | 61% |
| World Influenza Vaccines Market 2011-2021 |
Feb 2011 | £1,499 | 50% |
- Results 1 - 13 of 13
-
-
- 1
-
-
